Die Politisierung der wissenschaftlichen Forschung ist mit einem hohen Preis verbunden
https://www.bloomberg.com/opinion/articles/2025-08-20/executive-orders-impacting-nih-come-with-a-price?accessToken=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzb3VyY2UiOiJTdWJzY3JpYmVyR2lmdGVkQXJ0aWNsZSIsImlhdCI6MTc1NTY5MDY4OCwiZXhwIjoxNzU2Mjk1NDg4LCJhcnRpY2xlSWQiOiJUMUFIOE9HUEZIUFQwMCIsImJjb25uZWN0SWQiOiJBQkE5NzNFNjA3NkQ0NjMyODJFMDAyN0QyM0JDNTg5MyJ9.5ryiCL2tiLsRO6s5S9IyhVMh61V3HZh3XrTQnvjmaPc
2 Kommentare
well, yes, but it’s also utterly inevitable that anything that is used for decision making will become politicized in an effort to influence the decisions made.
“The source of the holdup is a quiet internal policy requiring projects to undergo not just scientific review, but political scrutiny. No longer can a grant receive the green light unless someone, somewhere, combs through it to be sure no money would be spent in defiance of Trump’s many executive orders — particularly those related to diversity, equity and inclusion, as well as foreign influence and gender-related policies.”
To do this to health research, especially, has serious ramifications for the rest of the world. US medical research is (was) some of the best funded in the world, and new research done there would enable cascading advancements across the globe.
That’s not to say that other countries aren’t pulling their weight in high quality research in crucial areas of health, but some problems – like developing new drugs fast enough to keep up with antibiotic resistance – just need money thrown at them and that’s where the US research landscape excels.
“The goal of these political reviews, of course, is to weed out “offending” grants. But it also allows Vought to claw back money that Congress allocated to the agency: if the NIH can’t spend its full budget by Sept. 30, the remaining funds return to the US Treasury.”
I wonder what they’ll spend it on?